External quality assessment of point-of-care methods: Model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials

Clinical Chemistry

Volumn 59, Issue 2, 2013, Pages 363-371

  Stavelin, Anne ^a,b   Petersen, Per Hyltoft ^a   Sølvik, Una Ø ^b   Sandberg, Sverre ^b,c  

^a Haraldsplass Deaconess Hospital   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT PARTICIPATION; POINT OF CARE TESTING; PRIMARY HEALTH CARE; QUALITY CONTROL; SYSTEMATIC ERROR;

BIAS (EPIDEMIOLOGY); HUMANS; INTERNATIONAL NORMALIZED RATIO; MODELS, STATISTICAL; PATIENT SELECTION; POINT-OF-CARE SYSTEMS; QUALITY ASSURANCE, HEALTH CARE;

EID: 84873199537     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.191957     Document Type: Article

References (29)

1. Klee GG, Westgard JO. Quality management. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz fundamentals of clinical chemistry. 6th ed. Oxford: Elsevier Saunders; 2008. p 249 -62.
2. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011;57:1670-80.
3. Libeer JC, Baadenhuijsen H, Fraser CG, Petersen PH, Ricos C, Stockl D, Thienpont L. Characterization and classification of external quality assessment schemes (EQA) according to objectives such as evaluation of method and participant bias and standard deviation. External Quality Assessment (EQA) Working Group A on Analytical Goals in Laboratory Medicine. Eur J Clin Chem Clin Biochem 1996;34:665-78.
4. Miller WG, Myers GL, Lou Gantzer M, Kahn SE, Schonbrunner ER, Thienpont LM, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011;57:1108 -17.
5. Lippi G, Plebani M, Favaloro EJ, Trenti T. Laboratory testing in pharmacies. Clin Chem Lab Med 2010;48:943-53.
6. International Organization for Standardization. Point-of-care testing (POCT): requirements for quality and competence. ISO 22870. Geneva: International ISO; 2005.
7. CLSI. Quality management: approaches to reducing errors at the point of care; approved guide-line. CLSI document POCT07-A. Wayne (PA): CLSI; 2010.
8. NCCLS/CLSI. Point-of-care monitoring of anticoagulation therapy; approved guideline. NCCLS/CLSI document H49-A. Wayne (PA): NCCLS/CLSI; 2004.
9. Perry DJ, Fitzmaurice DA, Kitchen S, Mackie IJ, Mallett S. Point-of-care testing in haemostasis. Br J Haematol 2010;150:501-14.
10. Nissinen A, Stranden P, Myllys R, Takkinen J, Bjorkman Y, Leinikki P, Siitonen A. Point-of-care testing of group A streptococcal antigen: performance evaluated by external quality assessment. Eur J Clin Microbiol Infect Dis 2009;28:17-20.
11. Van Blerk M, Coucke W, Chatelain B, Goossens W, Jochmans K, Meeus K, et al. External quality assessment in the measurement of haemoglobin by blood gas analysers in Belgium. Scand J Clin Lab Invest 2007;67:735-40.
12. Wood WG. Problems and practical solutions in the external quality control of point of care devices with respect to the measurement of blood glucose. J Diabetes Sci Technol 2007;1:158-63.
13. Bjelkaroy WI, Sandberg S, Thue G, Digranes A, Hoiby EA, Lermark G, Melby KK. [Quality assessment of urine dip-slides in primary care]. Tidsskr Nor Laegeforen 2006;126:149 -52. [Norwegian]
14. Stavelin A, Meijer P, Kitchen D, Sandberg S. External quality assessment of point-of-care international normalized ratio (INR) testing in Europe. Clin Chem Lab Med 2012;50:81-8.
15. CLSI. Method comparison and bias estimation using patient samples; approved guideline. 2nd ed (interim revision). CLSI document EP09 -A2-IR. Wayne (PA): CLSI; 2010.
16. Sandberg S, Nordin G, Martensson A, Grinsted P, Jensen E, Jacobsen CE, Monsen G. [Laboratory equipment for primary health care should be tested by independent authorities. Scandinavian SKUP is a good alternative]. Lakartidningen 2008; 105:3334-6; 3338-9. [Swedish]
17. Owren PA. Thrombotest. A new method for controlling anticoagulant therapy. Lancet 1959;2:754-8.
18. Lindahl TL, Egberg N, Hillarp A, Odegaard OR, Edlund B, Svensson J, et al. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples. Thromb Haemost 2004;91: 1223-31.
19. Burnett RW. Accurate estimation of standard deviations for quantitative methods used in clinical chemistry. Clin Chem 1975;21:1935-8.
20. CLSI. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline. 5th ed. CLSI document H21-A5. Wayne (PA): CLSI; 2008.
21. van Geest-Daalderop JH, Mulder AB, Boonman-de Winter LJ, Hoekstra MM, van den Besselaar AM. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005;51:561-8.
22. Favaloro EJ. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature: only a part of the story. Thromb Haemost 2008;99:1122-3.
23. Regionernes Lønnings-og Takstnævn (RLTN) og Praktiserende Lægers Organisation (PLO). Kvalitetssikring og kvalitetskrav til laboratoriemedicinske aktiviteter i almen praksis. Konsensusdokument, Danmark; 2010. http://skup.dk/files/15/2010-kvalitetssikring-og-kvalitetskrav.pdf. (Accessed November 2012).
24. Ross JW, Miller WG, Myers GL, Praestgaard J. The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods. Arch Pathol Lab Med 1998;122:587-608.
25. Thienpont LM, Stockl D, Friedecky B, Kratochvila J, Budina M. Trueness verification in European external quality assessment schemes: time to care about the quality of the samples. Scand J Clin Lab Invest 2003;63:195-201.
26. Horsti J, Uppa H, Vilpo JA. Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents. Clin Chem 2005;51:553-60.
27. Solvik UO, Petersen PH, Monsen G, Stavelin AV, Sandberg S. Discrepancies in international normalized ratio results between instruments: a model to split the variation into subcomponents. Clin Chem 2010;56:1618 -26.
28. Miller WG, Erek A, Cunningham TD, Oladipo O, Scott MG, Johnson RE. Commutability limitations influence quality control results with different reagent lots. Clin Chem 2011;57:76-83.
29. Kristensen GB, Christensen NG, Thue G, Sandberg S. Between-lot variation in external quality assessment of glucose: clinical importance and effect on participant performance evaluation. Clin Chem 2005;51:1632-6.